Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain
mediaposted on 08.04.2021, 14:06 by Adis journals on behalf of, Kirsi Norrbacka, Antoni Sicras-Mainar, Jeremie Lebrec, Esther Artime, Silvia Díaz, Santiago Tofé-Povedano, Ignacio Hernández, Irene Romera
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.